Tanja Dowe, CEO of Debiopharm Innovation Fund – Interview Series
Tanja Dowe is the CEO of Debiopharm Innovation Fund, the corporate venture capital arm of Debiopharm Group. The fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development.
Debiopharm Innovation Fund is known …